Risperdal

J&J Settles Most Risperdal Lawsuits, With $800 Million in Expenses

Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue ...

October 30, 2021BY Reuters
How Much of Our Tax Money Goes to Big Pharma? A Lot.

After an 18 month investigation into the high cost of Gilead's hepatitis C drug Sovaldi—initially listed at $84,000 ...

February 20, 2016BY Martha Rosenberg

TOP NEWS